The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luft, T.
Right arrow Articles by Cebon, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luft, T.
Right arrow Articles by Cebon, J.
The Journal of Immunology, 2001, 167: 2529-2537.
Copyright © 2001 by The American Association of Immunologists

Exogenous Peptides Presented by Transporter Associated with Antigen Processing (TAP)-Deficient and TAP-Competent Cells: Intracellular Loading and Kinetics of Presentation1

Thomas Luft2,*,{dagger}, Mark Rizkalla*, Tsin Yee Tai*, Qiyuan Chen*, Roderick I. MacFarlan{ddagger}, Ian D. Davis*, Eugene Maraskovsky* and Jonathan Cebon*

* Melbourne Tumor Biology Branch, Ludwig Institute for Cancer Research, Austin and Repatriation Medical Centre, Heidelberg, Victoria, Australia; {dagger} University of Heidelberg, Heidelberg, Germany; and {ddagger} Department of Molecular Biology and Immunology, CSL Ltd., Parkville, Melbourne, Australia

This study investigates the differential capacity of TAP-deficient T2 cells, TAP-competent EBV cells, and immature and mature dendritic cells to present peptides to preformed CTL lines. It demonstrates that presentation of exogenous peptides involves peptide uptake and loading onto newly synthesized MHC class I molecules. This mechanism was best demonstrated for low affinity peptides in the presence of irrelevant peptides competing for HLA binding sites. Under these circumstances, inhibition of protein synthesis with cycloheximide or vesicular trafficking with brefeldin A significantly reduced the presentation of low affinity peptides. This was not restored by adding exogenous {beta}2-microglobulin to stabilize the MHC complex on the cell surface. In contrast, presentation of high affinity peptides was not sensitive to cycloheximide or brefeldin A, which suggests that different mechanisms may operate for presentation of high and low affinity peptides by TAP-competent cells. High affinity peptides can apparently compete with peptides in preloaded MHC class I molecules at the cell surface, whereas low affinity peptides require empty MHC molecules within cells. Accordingly, very high concentrations of exogenous low affinity peptides in conjunction with active MHC class I metabolism were required to allow successful presentation against a background of competing intracellular high affinity peptides in TAP-competent cells. These findings have implications for the design of peptide and protein-based vaccines.




This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
X. Weng, S. Lu, M. Zhong, Z. Liang, G. Shen, J. Chen, and X. Wu
Allo-restricted CTLs generated by coculturing of PBLs and autologous monocytes loaded with allogeneic peptide/HLA/IgG1-Fc fusion protein
J. Leukoc. Biol., March 1, 2009; 85(3): 574 - 581.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
D.-W. Liu, Y.-C. Yang, H.-F. Lin, M.-F. Lin, Y.-W. Cheng, C.-C. Chu, Y.-P. Tsao, and S.-L. Chen
Cytotoxic T-Lymphocyte Responses to Human Papillomavirus Type 16 E5 and E7 Proteins and HLA-A*0201-Restricted T-Cell Peptides in Cervical Cancer Patients
J. Virol., March 15, 2007; 81(6): 2869 - 2879.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
F. Bettosini, M. T. Fiorillo, A. Magnacca, L. Leone, M. R. Torrisi, and R. Sorrentino
The C Terminus of the Nucleoprotein of Influenza A Virus Delivers Antigens Transduced by Tat to the trans-Golgi Network and Promotes an Efficient Presentation through HLA Class I
J. Virol., December 15, 2005; 79(24): 15537 - 15546.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
E. Elkord, P. E. Williams, H. Kynaston, and A. W. Rowbottom
Differential CTLs specific for prostate-specific antigen in healthy donors and patients with prostate cancer
Int. Immunol., October 1, 2005; 17(10): 1315 - 1325.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
X.-L. Huang, Z. Fan, B. A. Colleton, R. Buchli, H. Li, W. H. Hildebrand, and C. R. Rinaldo Jr.
Processing and Presentation of Exogenous HLA Class I Peptides by Dendritic Cells from Human Immunodeficiency Virus Type 1-Infected Persons
J. Virol., March 1, 2005; 79(5): 3052 - 3062.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Gnjatic, D. Atanackovic, M. Matsuo, E. Jager, S. Y. Lee, D. Valmori, Y.-T. Chen, G. Ritter, A. Knuth, and L. J. Old
Cross-Presentation of HLA Class I Epitopes from Exogenous NY-ESO-1 Polypeptides by Nonprofessional APCs
J. Immunol., February 1, 2003; 170(3): 1191 - 1196.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
I. D. Davis, M. Jefford, P. Parente, and J. Cebon
Rational approaches to human cancer immunotherapy
J. Leukoc. Biol., January 1, 2003; 73(1): 3 - 29.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
T. Luft, P. Luetjens, H. Hochrein, T. Toy, K.-A. Masterman, M. Rizkalla, C. Maliszewski, K. Shortman, J. Cebon, and E. Maraskovsky
IFN-{alpha} enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells
Int. Immunol., April 1, 2002; 14(4): 367 - 380.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.